{
    "2019-05-02": [
        [
            {
                "time": "",
                "original_text": "【药明康德】Q1点评：平台型CRO巨头优势尽显，充分受益全球创新浪潮",
                "features": {
                    "keywords": [
                        "药明康德",
                        "CRO",
                        "平台型",
                        "全球创新浪潮"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}